Capital Markets

Calgary – October 12, 2026 -- XORTX Therapeutics Inc. has elected to voluntarily delist its common shares from the TSX Venture Exchange (TSXV), ending a dual listing it says no longer justifies its cost. The company will keep its primary listing on Nasdaq (XRTX) and its Frankfurt listing (ANU).

XORTX, a late-stage clinical pharmaceutical company developing therapies for gout and progressive kidney disease, will announce the timing of the delisting in a separate press release.

XORTX cites duplicate fees and regulatory complexity as reasons for leaving the TSXV

The company said a comprehensive evaluation concluded that the TSXV listing does not justify its costs and administrative requirements. It also said the different regulatory environments create challenges.

XORTX expects the delisting to deliver four outcomes:

Calgary – October 12, 2026 -- XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX) has rescinded a US$2.5 million investor relations agreement with IR Agency LLC and recovered the full fee. The company is postponing its marketing push while it exits the TSX Venture Exchange.

XORTX terminates 90-day IR contract effective August 7, 2026

The agreement, dated May 13, 2026, ran for 90 days from May 18, 2026. It covered 10 marketing days of news distribution campaigns for an aggregate fee of US$2.5 million, payable in advance. The fee had been fully earned on receipt and was non-refundable.

Both parties agreed to rescind the arrangement, and all services under it have been discontinued. The funds were returned to XORTX in August 2026. The release cites both August 7 and August 14 as the return date.

Calgary – October 12, 2026 -- XORTX Therapeutics Inc. has re-engaged IR Agency LLC for investor relations and marketing services, following completion of its voluntary delisting from the TSX Venture Exchange.

XORTX restores IR Agency LLC consulting agreement on previously disclosed terms

The new consulting agreement carries substantially the same terms the company disclosed in news releases dated May 19, 2026 and August 28, 2026. The source gives no fee, share-based compensation or contract-length figures for the renewed engagement.

Delisting from TSX Venture Exchange precedes the renewed marketing push

The re-engagement comes after XORTX completed the delisting it had announced earlier. The company's filings reference ongoing compliance with Nasdaq listing standards, and its release states that Nasdaq has not approved or disapproved its contents.

Vancouver – October 12, 2026 -- Rio Silver Inc. (TSX.V: RYO) has received approval to trade on the OTCQB Venture Market under the symbol "RYOOF", and has granted 850,000 incentive stock options to consultants.

OTCQB listing opens U.S. retail and institutional access to Rio Silver shares

The OTCQB is a U.S. trading platform operated by OTC Markets Group Inc. for developing and entrepreneurial-stage companies. The Securities and Exchange Commission recognizes it as an "established public market" for determining the public market price when registering securities for resale.

Rio Silver says the listing gives U.S. retail and institutional investors improved access to its shares. The company frames the move as coming at a point when global silver production is decreasing and interest in pure-play silver producers is accelerating, particularly where the majority of the co-product is gold. The company provided no market data to support either claim.

Baoding – – October 09, 2026 -- NYSE Regulation has granted IT Tech Packaging (NYSE American: ITP) a plan period through April 15, 2027 to file three overdue SEC reports, keeping the paper maker listed while it works to restore compliance.

NYSE Regulation accepted ITP's extension request on October 7, 2026

ITP submitted the request on October 1, 2026. Section 1007 of the NYSE American Company Guide requires one when a company cannot cure a filing delinquency within the first six months of the maximum 12-month cure period. NYSE Regulation's letter of October 7 accepted the request and covers the delayed filings plus any subsequently delayed filings.

New York – October 08, 2026 -- Bluerock Private Real Estate Fund (NYSE: BPRE) will pay a cash distribution of $0.1371 per share for October 2026, representing an annualized market distribution rate of approximately 12.9% based on its $12.80 closing price on October 08, 2026.

Shareholders of record by October 21 qualify for the payout

The distribution translates to a 7.3% rate on net asset value and an annualized tax-equivalent rate of 20.1%, calculated using a 37% maximum federal tax rate, the 3.8% Medicare surtax, and a 5% average state tax assumption. The fund has announced four distribution increases since its December 2025 NYSE listing.

New York – October 08, 2026 -- Orca and Loopscale have merged into a single entity called Formation, combining trading, credit and vault infrastructure to finance AI, robotics and defense companies that fall outside traditional capital market structures.

Formation targets a $3 trillion AI infrastructure financing gap

Apollo estimates nearly $3 trillion will be needed for AI infrastructure alone through 2028, capital that many frontier companies struggle to access because fixed underwriting, legal, servicing and distribution costs favor large, standardized deals. Formation says it will cut the cost and complexity of structuring, distributing and financing these assets by unifying origination, vault strategies and distribution on top of the existing Orca and Loopscale protocols.

Los Angeles – – October 08, 2026 -- Live Nation Entertainment (NYSE: LYV) has priced a dual-currency debt offering totaling $730 million in 7.125% senior notes due 2032 and €600 million in 6.125% senior notes due 2032, with both tranches issued at 100.000% of face value.

Proceeds will retire existing 2027 secured notes

Closing set for October 08, 2026

Stockholm – October 07, 2026 -- SciBase Holding AB has recalculated the terms of its series TO 2 warrants following a rights issue of shares resolved by its board on September 3, 2026, cutting the subscription ratio to 0.01 shares per warrant.

Subscription price drops to SEK 37.47 per share under new warrant terms

Each TO 2 warrant now entitles the holder to subscribe for 0.01 new shares at SEK 37.47 per share, down from the original terms set when the instrument was issued alongside SciBase's April 2024 capital raise. The adjustment follows contractual provisions requiring recalculation of warrant terms whenever the company conducts a subsequent rights issue.

Stockholm – October 07, 2026 -- SciBase Holding AB has resolved on a set-off share issue of 60,000 new shares to Bergs Securities AB, settling part of the guarantee compensation owed for underwriting the company's recently completed rights issue.

Board approves compensation shares at SEK 15 apiece

The Board of Directors resolved on the Compensation Issue on October 7, 2026, under authorization granted at the Annual General Meeting on May 19, 2026. The subscription price of SEK 15 per share matches the price set in the underlying rights issue. Payment was made entirely through set-off against SEK 0.9 million of Bergs Securities' claim for guarantee compensation, and all 60,000 shares have been subscribed for and allotted.